IOL Chemicals and Pharmaceuticals Limited (IOLCP) reports Q1 FY27 with highest-ever revenue, up 37.1% YoY, driven by strong Pharmaceuticals and Chemicals seg.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) reports a 11.5% revenue increase and a 68.2% surge in PAT for Q4 & FY26.
IOL Chemicals and Pharmaceuticals Limited (IOLCP) reports Q4 & FY26 results with highest-ever quarterly revenue and significant EBITDA margin growth.